Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Salivary interleukins as possible markers of periodontal tissue destruction

July 5, 2012

Phase I results available for OPB-51602

July 5, 2012

Buparlisib administered with trametinib dimethyl sulfoxide in cancer study

July 5, 2012

ARRY-614 active in phase I trial

July 5, 2012

Dinaciclib is highly active in phase I trial in chronic lymphocytic leukemia

July 4, 2012

Navitoclax administered with bendamustine/rituximab in phase I study

July 4, 2012

Scientists discover cause of Sengers syndrome / News in Context

July 4, 2012

AMG-900 shows promise in first-in-human trial

July 4, 2012

Safety results presented on new MedImmune immunotherapeutic

July 4, 2012

Milatuzumab evaluated in elderly patients with chronic lymphocytic leukemia

July 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...